Accretive Wealth Partners, LLC Becton Dickinson & CO Transaction History

Accretive Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $561,028 - $658,253	-2,390 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$243.64 - $270.48 $582,299 - $646,447	2,390 New	2,390 $636,000
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $1.1 Million - $1.2 Million	-4,780 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $13,265 - $14,618	57 Added 1.21%	4,780 $1.18 Million
Q2 2021 Aug 13, 2021	BUY	$232.65 - $254.58 $305,469 - $334,263	1,313 Added 38.5%	4,723 $1.15 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $65,681 - $72,697	283 Added 9.05%	3,410 $829,000
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $693,943 - $769,054	3,127 New	3,127 $783,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Accretive Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Accretive Wealth Partners, LLC with notifications on news.